Boothbay Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Boothbay Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Sell	12,900 -132,800	-91%	-$7.63M	0.01%	1274
2026 Q1	$8.84M	Buy	+145,700	New	+$8.49M	0.11%	166
2025 Q4	–	Sell	-291,200	Closed	-$13.1M	–	1991
2025 Q3	$13.1M	Buy	+291,200	New	+$13.6M	0.19%	101
2023 Q2	–	Sell	-71,300	Closed	-$4.94M	–	1843
2023 Q1	$4.94M	Buy	+71,300	New	+$5.03M	0.1%	255
2022 Q4	–	Sell	-3,800	Closed	-$270K	–	2018
2022 Q3	$270K	Sell	3,800 -26,000	-87%	-$1.89M	0.01%	1604
2022 Q2	$2.29M	Buy	29,800 +20,900	+235%	+$1.59M	0.06%	498
2022 Q1	$650K	Buy	+8,900	New	+$598K	0.02%	1159
2019 Q2	–	Sell	-293	Closed	-$1.4M	–	752
2019 Q1	$1.4M	Sell	293 -119	-29%	-$5.93K	0.14%	167
2018 Q4	$2.14M	Buy	+412	New	+$22.1K	0.31%	61
2018 Q1	–	Sell	-586	Closed	-$3.59M	–	704
2017 Q4	$3.59M	Buy	+586	New	+$36.7K	0.53%	44

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boothbay Fund Management's BMY Position: Q2 2026 in Review

Boothbay Fund Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $329K and bringing the position to 60,305 shares worth $3.47M. The position accounts for 0.05% of the portfolio, ranked #462.

Boothbay Fund Management first reported a position in BMY in Q1 2016 and has held it in 26 quarters since. The position peaked at $5.13M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Boothbay Fund Management held 60,305 shares of Bristol-Myers Squibb worth $3.47M as of Q2 2026.
Boothbay Fund Management bought 5,738 Bristol-Myers Squibb shares in Q2 2026, an estimated $329K.
Bristol-Myers Squibb made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #462 holding.
Boothbay Fund Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 26 quarters since.
Boothbay Fund Management's Bristol-Myers Squibb position peaked at $5.13M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.